k Erythropoietin molecule bound to receptors. Computer model of a molecule of erythropoietin EPO orange bound to two extracellular EPO receptors pink and purple. EPO is a glycoprotein that is produced by the kidneys in response to low blood oxygen levels. It stimulates the erythrocyte red blood cell precursor cells in the bone marrow to mature into erythrocytes. It is used therapeutically to treat anaemia caused by renal failure or chemotherapy. It is also abused by athletes who use it to enhance their performance by increasing blood oxygen levels. However, this use also causes thickening of the blood which can lead to death. Editorial Stock Photo - Afloimages
Sign up
Login
All images
Erythropoietin molecule bound to receptors. Computer model of a molecule of erythropoietin (EPO) (orange) bound to two extracellular EPO receptors (pink and purple). EPO is a glycoprotein that is produced by the kidneys in response to low blood oxygen levels. It stimulates the erythrocyte (red blood cell) precursor cells in the bone marrow to mature into erythrocytes. It is used therapeutically to treat anaemia caused by renal failure or chemotherapy. It is also abused by athletes who use it to enhance their performance by increasing blood oxygen levels. However, this use also causes thickening of the blood which can lead to death.
ED

Erythropoietin molecule bound to receptors. Computer model of a molecule of erythropoietin (EPO) (orange) bound to two extracellular EPO receptors (pink and purple). EPO is a glycoprotein that is produced by the kidneys in response to low blood oxygen levels. It stimulates the erythrocyte (red blood cell) precursor cells in the bone marrow to mature into erythrocytes. It is used therapeutically to treat anaemia caused by renal failure or chemotherapy. It is also abused by athletes who use it to enhance their performance by increasing blood oxygen levels. However, this use also causes thickening of the blood which can lead to death.

Details

ID
10571661

Collection

License type
Editorial

Photographer

Creation date
15-11-2010

Contact Aflo for all commercial uses.


Keywords
More
Sign in
Member access
Login not found.